blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1350525

EP1350525 - Matrix-free osteogenic devices, implants and methods thereof [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.07.2015
Database last updated on 26.03.2026
Most recent event   Tooltip24.07.2015Application deemed to be withdrawnpublished on 26.08.2015  [2015/35]
Applicant(s)For all designated states
Mariel Therapeutics, Inc.
135 East 57th Street, 24th floor
New York, NY 10022 / US
[2014/40]
Former [2011/23]For all designated states
STRYKER CORPORATION
2825 Airview Boulevard
Kalamazoo, MI 49002 / US
Former [2003/41]For all designated states
STRYKER CORPORATION
2725 Fairfield Road, P.O. Box 4085
Kalamazoo, Michigan 49003-4085 / US
Inventor(s)01 / Rueger, David C.
81 Pine Street
Southborough, MA 01772 / US
02 / Tucker, Marjorie, M.
132 Robert Road
Holliston, MA 01746 / US
 [2003/41]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2003/41]VOSSIUS & PARTNER
Siebertstrasse 4
81675 München / DE
Application number, filing date03009751.305.02.1998
[2003/41]
Priority number, dateUS19970037327P07.02.1997         Original published format: US 37327 P
US19970047909P29.05.1997         Original published format: US 47909 P
[2003/41]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1350525
Date:08.10.2003
Language:EN
[2003/41]
Type: A3 Search report 
No.:EP1350525
Date:10.12.2003
[2003/50]
Search report(s)(Supplementary) European search report - dispatched on:EP28.10.2003
ClassificationIPC:A61K38/18, C07K14/51, A61L27/22
[2003/50]
CPC:
A61K38/1875 (EP,US); A61L27/227 (EP,US); A61P19/08 (EP);
A61L2430/02 (EP,US)
C-Set:
A61L27/227, A61F2/28, A61K38/18 (US,EP)
Former IPC [2003/41]A61L27/22, A61K38/18
Designated contracting statesDE,   FR,   GB,   IT [2004/36]
Former [2003/41]AT,  BE,  CH,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
TitleGerman:Matrixlose osteogene Vorrichtungen und Implantate und Verfahren zu deren Verwendung[2003/41]
English:Matrix-free osteogenic devices, implants and methods thereof[2003/41]
French:Dispositif ostéogenique sans matrice, implants et méthodes d'utilisation associées[2003/41]
Examination procedure21.05.2004Examination requested  [2004/30]
12.06.2004Loss of particular rights, legal effect: designated state(s)
30.09.2004Despatch of communication of loss of particular rights: designated state(s) AT, BE, CH, DK, ES, FI, GR, IE, LU, MC, NL, PT, SE
15.05.2008Despatch of a communication from the examining division (Time limit: M04)
18.09.2008Reply to a communication from the examining division
24.02.2011Despatch of a communication from the examining division (Time limit: M04)
05.07.2011Reply to a communication from the examining division
08.03.2013Despatch of a communication from the examining division (Time limit: M04)
12.07.2013Reply to a communication from the examining division
23.09.2014Cancellation of oral proceeding that was planned for 25.09.2014
25.09.2014Date of oral proceedings (cancelled)
15.10.2014Communication of intention to grant the patent
26.02.2015Application deemed to be withdrawn, date of legal effect  [2015/35]
07.04.2015Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2015/35]
Parent application(s)   TooltipEP98904920.0  / EP0957943
Divisional application(s)EP10010863.8  / EP2332564
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19980904920) is  15.05.2001
Fees paidRenewal fee
05.06.2003Renewal fee patent year 03
05.06.2003Renewal fee patent year 04
05.06.2003Renewal fee patent year 05
05.06.2003Renewal fee patent year 06
15.01.2004Renewal fee patent year 07
28.02.2005Renewal fee patent year 08
28.02.2006Renewal fee patent year 09
27.02.2007Renewal fee patent year 10
25.02.2008Renewal fee patent year 11
26.02.2009Renewal fee patent year 12
24.02.2010Renewal fee patent year 13
23.02.2011Renewal fee patent year 14
24.02.2012Renewal fee patent year 15
27.02.2013Renewal fee patent year 16
27.02.2014Renewal fee patent year 17
11.02.2015Renewal fee patent year 18
Penalty fee
Penalty fee Rule 85a EPC 1973
15.07.2004AT   M01   Not yet paid
15.07.2004BE   M01   Not yet paid
15.07.2004CH   M01   Not yet paid
15.07.2004DK   M01   Not yet paid
15.07.2004ES   M01   Not yet paid
15.07.2004FI   M01   Not yet paid
15.07.2004GR   M01   Not yet paid
15.07.2004IE   M01   Not yet paid
15.07.2004LU   M01   Not yet paid
15.07.2004MC   M01   Not yet paid
15.07.2004NL   M01   Not yet paid
15.07.2004PT   M01   Not yet paid
15.07.2004SE   M01   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X] EP0308238  (ETHICON INC et al.) [X] 1-19 * page 3, line 37 - line 55 * * page 4, line 15 - line 65; example - *
 [X] WO9533502  (CREATIVE BIOMOLECULES INC et al.) [X] 1-19 * page 19, line 1 * * page 20, line 1 - line 6; example - *
 [X] FR2564732  (KYOCERA CORP et al.) [X] 1-19 * page 4, line 21 - line 37; example -; claim - *
 [X] US5158934  (AMMANN ARTHUR J et al.) [X] 1-19 * column 10, line 34 - line 65 * * column 11, line 15 - line 42; claim - *
 [X] WO9325246  (STRYKER CORP et al.) [X] 1-5 * page 7, line 5 - line 14 * * page 20, line 10 - line 20; claim 13 *
 [X] EP0321277  (COLLAGEN CORP et al.) [X] 1 * claim - *
 [PX] WO9721447  (STRYKER CORP et al.) [PX] 1-19 * page 47, line 32 - line 37 * * page 48; claim - *
 [Y] EP0419275  (OSTEOTECH INC et al.) [Y] 1-19 * the whole document *
 [Y] EP0688869  (GENETICS INST et al.) [Y] 1-19 * page 5, line 45 - line 54; claim - *
 [A] WO9640297  (STRYKER CORP et al.) [A]
 [A] WO8600526  (CAPLAN ARNOLD I et al.) [A]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.